arrow
A

Anna Di Benedetto

National Cancer Institute
H指数:25
被引数:2,396

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study

铂类新辅助化疗及DNA损伤反应生物标志物在TNBC中的预测作用:NeoCarbo研究

2026-05-290
OAAI
Multi-omics analyses integration reveals a novel TRF2-miR-181a-5p-S100A10 regulatory axis in colon cancer

多组学分析整合揭示结肠癌中一种新型的TRF2-miR-181a-5p-S100A10调控轴。

2025-10-220
OAAI
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B (vol 23, pg 1379, 2022)

I型ifn通过触发表观遗传调节因子KDM1B促进癌细胞干细胞性 (第23卷,1379页,2022页)

2024-09-170
OAAI
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication
2024-03-090
OAAI
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

I型ifn通过触发表观遗传调节因子KDM1B促进癌细胞干细胞性

2022-08-2467
OAAI
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

ChangeHER试验中转移性乳腺癌HER2-positivity增益的预后相关性

2021-07-026
OAAI
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

DNA损伤和修复生物标志物在接受新辅助激素治疗的老年激素受体阳性乳腺癌患者中的预后相关性: 来自真实世界的证据

2019-08-182
OAAI
hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis
2018-06-1520
OAAI
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting
2018-05-1617
OAAI
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study
2018-05-0226
OAAI
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression

男性乳腺癌ATR-Chk1和ATM-Chk2通路分析揭示ATR表达的预后意义

2017-08-1414
OAAI
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer
2017-05-1416
OAAI
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy
2017-04-0719
OAAI
Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
2017-03-2856
OAAI